Click here for PDF
(WASHINGTON, D.C.) January 3, 2019 – Mark Mansour has joined Locke Lord’s Washington, D.C., office as a Partner in the Firm’s IP Pharmaceutical Practice Group. With more than two decades of experience handling federal Food and Drug Administration (FDA) regulatory matters, he will strengthen the Firm’s FDA practice both in Washington, D.C., and across the Firm.
Mansour, who joins Locke Lord from Foley Hoag where he was a Partner, has significant experience working with clients in the food, pharmaceutical, medical device, dietary supplements and cosmetic industries to develop and implement strategies for regulatory approvals, compliance and enforcement actions, crisis management, rulemaking and public policy issues. He counsels corporations and organizations on how to negotiate effectively with government agencies in the United States and key global markets.
“Mark is a well-known and widely respected lawyer, who represents a very strong, strategic addition to our IP team. His practice naturally aligns with many key areas for the Firm, including IP pharmaceutical, advertising, cosmetics, food and beverage, health care, life sciences and IP prosecution, among others. We’re thrilled to add an FDA lawyer of Mark’s caliber to the team,” said Alan Clement, Chair of Locke Lord’s IP Department.
“Mark’s arrival to our D.C. office adds considerable depth to the Firm’s capabilities handling FDA regulatory and enforcement matters, public policy and strategy issues and government investigations,” said Denise Hanna, Managing Partner of Locke Lord’s Washington, D.C., office and Co-Chair of the Firm’s Health Care Practice Group. “His ample knowledge and experience nicely complement our health care and life sciences practices as well as our work involving FTC advertising and FDA consumer product safety regulation.”
Mansour is a leader in the development of regulatory pathway strategies for approvals in the United States and many international markets. He has been actively involved with industry and government to achieve solutions to issues such as the regulation of biotechnology and nanotechnology and also is active in domestic and international industry groups involving the key regulated industries. Throughout his seasoned career, he has taken a lead role in drafting industry comments in response to key rulemaking activities.
“Locke Lord has a stellar reputation for collaboration among its top-tier lawyers combined with a strong platform that provides an excellent opportunity to continue to grow my FDA practice. I’m particularly impressed with Locke Lord’s work in generic pharma, life sciences, medical devices, cosmetics and health care,” said Mansour.
Mansour is recognized as one of the most effective crisis managers in the food, drug and medical device fields, having been actively involved in the representation of clients affected by many of the largest and most complex recalls since 1997. He has also assisted clients in managing numerous Federal Trade Commission consumer protection matters, including investigations, enforcement actions, negotiations and consent decrees for marketing, advertising and privacy matters, as well as advertising disputes before the National Advertising Division of the Better Business Bureaus.
About Locke Lord LLP
Locke Lord is a full-service law firm with global reach and 20 offices designed to meet clients’ needs around the world. The Firm has a history that spans more than 130 years and is a worldwide leader in the middle market sector. Locke Lord advises clients across a broad spectrum of industries including energy, financial services, fund formation, health care, insurance and reinsurance, private equity and venture capital, public finance, real estate, and technology, media and telecommunications, while providing a wealth of experience through its complex litigation, intellectual property, tax, regulatory and transactional teams.